Richard Alcock
Corporate Officer/Principal at Office of Technology Development
Profile
Rich oversees the Material Transfer Agreements (MTA) process within the Technology Transactions group of OTD.
His team manages all of Harvard’s material transfer requests, which govern the flow of research materials both to and from Harvard researchers.
He is also responsible for negotiating and signing confidential disclosure agreements handled by OTD, as well as the licensing of Harvard materials to for-profit entities.
Rich joined OTD in 2012 after spending three years at Partners HealthCare in its Office of Research Ventures & Licensing.
He has also worked in the general counsel’s office at Critical Therapeutics, Inc. and in the business law departments of Boston law firms Hutchins, Wheeler and Dittmar, PC, and Hale and Dorr, LLP.
Rich holds a JD from Harvard Law School and a BA from Boston College.
Richard Alcock active positions
Companies | Position | Start |
---|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 2011-12-31 |
Former positions of Richard Alcock
Companies | Position | End |
---|---|---|
Critical Therapeutics, Inc. | Consultant / Advisor | - |
Training of Richard Alcock
Harvard Law School | Graduate Degree |
Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Critical Therapeutics, Inc. | Health Technology |
- Stock Market
- Insiders
- Richard Alcock